Compositions and methods for the biosynthesis of 1,4-butanediol and its precursors
US-2015368676-A1 · Dec 24, 2015 · US
US9284581B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9284581-B2 |
| Application number | US-201213597095-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 28, 2012 |
| Priority date | Dec 10, 2009 |
| Publication date | Mar 15, 2016 |
| Grant date | Mar 15, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A non-naturally occurring microbial organism having a 1,3-butanediol (1,3-BDO) pathway includes at least one exogenous nucleic acid encoding a 1,3-BDO pathway enzyme or protein expressed in a sufficient amount to produce 1,3-BDO. A method for producing 1,3-BDO that includes culturing the this non-naturally occurring microbial organism under conditions and for a sufficient period of time to produce 1,3-BDO.
Opening claim text (preview).
What is claimed is: 1. A non-naturally occurring microbial organism comprising: (1) a Wood-Ljungdahl pathway, wherein said microbial organism comprises at least one exogenous nucleic acid encoding a Wood-Ljungdahl pathway enzyme expressed in a sufficient amount to enhance carbon flux through acetyl-CoA, wherein said Wood-Ljungdahl pathway enzyme is selected from the group consisting of: a) a formate dehydrogenase that catalyzes the incorporation of CO2 into formate; b) a formyltetrahydrofolate synthetase that ligates formate to tetrahydrofolate to form 10-formyltetrahydrofolate, c) a methenyltetrahydrofolate cyclohydrolase that converts 10-formyltetrahydrofolate to methyltetrahydrofolate, d) a methylenetetrahydrofolate dehydrogenase that converts methyltetrahydrofolate to methenyltetrahydrofolate, e) a methylenetetrahydrofolate reductase that converts metheneyltetrahydrofolate to 5-methyltetrahydrofolate; f) a methyltetrahydrofolate:corrinoid protein methyltransferase that catalyzes the transfer of a methyl group from 5-methyltetrahydrofolate to corrinoid iron sulfur protein, g) a corrinoid iron-sulfur protein, h) a nickel-protein assembly protein, i) a ferredoxin, j) a acetyl-CoA synthase that catalyzes the condensation of the methylated corrinoid iron sulfur protein, carbon monoxide and coenzyme A, yielding acetyl-CoA, k) a carbon monoxide dehydrogenase that converts CO and water to CO2 while passing the electrons to a reduced acceptor, l) a pyruvate ferredoxin oxidoreductase that converts the pyruvate to acetyl-CoA or pyruvate dehydrogenase that converts the pyruvate to acetyl-CoA, and m) a pyruvate formate lyase that converts the pyruvate and CoA to acetyl-CoA; and (2) a 1,3-butanediol pathway that converts acetyl-CoA to 1,3-butanediol, wherein the 1,3-butanediol pathway comprises at least three enzymes selected from the group consisting of: a) an acetoacetyl-CoA thiolase that converts acetyl-CoA to acetoacetyl-CoA, b) an acetoacetyl-CoA reductase (CoA-dependent, alcohol forming) that converts acetoacetyl-CoA to 4-hydroxy,2-butanone, c) a 3-oxobutyraldehyde reductase (aldehyde reducing) that converts 3-oxobutyraldehyde into 4-hydroxybutanone, d) a 4-hydroxy,2-butanone reductase that converts 4-hydroxy,2-butanone to 1,3-butanediol, e) an acetoacetyl-CoA reductase (CoA-dependent, aldehyde forming) that converts acetoacetyl-CoA to 3-oxobutyraldehyde, f) a 3-oxobutyraldehyde reductase (ketone reducing) that converts 3-oxobutyraldehyde to 3-hydroxybutyraldehyde, g) a 3-hydroxybutyraldehyde reductase that converts 3-hydroxybutyraldehyde to 1,3-BDO, h) an acetoacetyl-CoA reductase (ketone reducing) that converts acetoacetyl-CoA to 3-hydroxybutyryl-CoA, i) a 3-hydroxybutyryl-CoA reductase (aldehyde forming) that converts 3-hydroxybutyryl-CoA to 3-hydroxybutyraldehyde, j) a 3-hydroxybutyryl-CoA reductase (alcohol forming) that converts 3-hydroxybutyryl-CoA to 1,3-butanediol, k) an acetoacetyl-CoA transferase, an acetoacetyl-CoA hydrolase, an acetoacetyl-CoA synthetase, or a phosphotransacetoacetylase/acetoacetate kinase that converts acetoacetyl-CoA to acetoacetate, l) an acetoacetate reductase that converts acetoacetate to 3-oxobutyraldehyde, m) a 3-hydroxybutyryl-CoA transferase, a 3-hydroxybutyryl-CoA hydrolase, or a 3-hydroxybutyryl-CoA synthetase that converts 3-hydroxybutyryl-CoA to 3-hydroxybutyrate, n) a 3-hydroxybutyrate reductase that converts 3-hydroxybutyrate to 3-hydroxybutyraldehyde; and o) a 3-hydroxybutyrate dehydrogenase that converts acetoacetate to 3-hydroxybutyrate. 2. The non-naturally occurring microbial organism of claim 1 , wherein the organism comprises exogenous nucleic acids encoding each of the Wood-Ljungdahl pathway enzymes (a)-(m). 3. The non-naturally occurring microbial organism of claim 1 , wherein at least one of the 1,3-BDO pathway enzymes is encoded by an exogenous nucleic acid. 4. The non-naturally occurring microbial organism of claim 1 , wherein said at least one exogenous nucleic acid is a heterologous nucleic acid. 5. The non-naturally occurring microbial organism of claim 1 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium. 6. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism uses a carbon feedstock selected from 1) methanol and CO, 2) methanol, CO 2 , and H 2 , 3) methanol, CO, CO 2 , and H 2 , 4) methanol and synthesis gas comprising CO and H 2 , 5) methanol and synthesis gas comprising CO, CO 2 , and H 2 , 6) one or more carbohydrates, 7) methanol and one or more carbohydrates, and 8) methanol. 7. A method for producing 1,3-BDO, comprising culturing the organism of claim 1 under conditions and for a sufficient period of time to produce 1,3-BDO. 8. A culture medium comprising 1,3-BDO produced according to the method of claim 7 . 9. The culture medium of claim 8 , wherein said culture medium is separated from the non-naturally occurring microbial organism. 10. A composition comprising a biosynthesized 1,3-BDO and the non-naturally occurring microbial organism of claim 1 . 11. A biosynthesized 1,3-BDO produced according to the method of claim 7 .
Related publications grouped by family.
Answers are generated from the same data shown on this page.